Noninvasive electrocardiographic imaging assessment of conduction system pacing: A novel algorithm to assess intraventricular synchrony
ECG imaging can bring a significant value into assessing the efficacy of new pacing modalities and provide much more data for precise determination of implantation outcome including detailed activation assessment and comparison with intrinsic conduction. Key ECGI values confirming proper ventricular activation have been defined, and corresponding 12-lead parameters were also identified, which allows to predict ventricular activation by using 12-lead ECG only.
Authors
- Ali Gharaviri (ORCID: https://orcid.org/0000-0003-1803-8237)
- Carlo de Asmundis (ORCID: https://orcid.org/0000-0001-9351-0760)
- Ingrid Overeinder (ORCID: https://orcid.org/0000-0003-0988-2698)
- Erwin Ströker (ORCID: https://orcid.org/0000-0001-9094-2576)
- Ivan Eltsov (ORCID: https://orcid.org/0000-0003-2832-9556)
- Luigi Pannone (ORCID: https://orcid.org/0000-0001-9769-1511)
- Frederik H. Verbrugge (ORCID: https://orcid.org/0000-0003-0599-9290)
- Roberto Scacciavillani (ORCID: https://orcid.org/0000-0002-6200-4088)
- Gezim Bala (ORCID: https://orcid.org/0000-0002-7613-0712)
- Gian‐Battista Chierchia (ORCID: https://orcid.org/0000-0003-2967-1345)
- Alvise Del Monte (ORCID: https://orcid.org/0000-0001-6672-4931)
- Andrea Sarkozy (ORCID: https://orcid.org/0000-0001-6327-0487)
- Domenico Giovanni Della Rocca (ORCID: https://orcid.org/0000-0003-3837-3462)
- Giacomo Talevi
- Alexandre Almorad (ORCID: https://orcid.org/0000-0002-9743-1661)
- Juan Sieira (ORCID: https://orcid.org/0000-0002-8865-2120)
- Qingguo Zeng
- Mark La Meir
- A Paparella
Institutions
- Vrije Universiteit Brussel (BE)
- Medtronic (United States) (US)
- Universitair Ziekenhuis Brussel (BE)
- ERN GUARD-Heart (NL)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1016/j.hroo.2024.11.026
- Citations
- 1
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.40